Secondary Angiosarcoma
1 clinical trials · Condition
◉ Watch Secondary Angiosarcoma
| Record | Firm | Date |
|---|---|---|
| Cemiplimab for Secondary Angiosarcomas (NCT04873375) | Radboud University Medical Center | 2022-01-01 |
Track Secondary Angiosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.